Bristol-Myers (BMY) Reports Mixed Q3 Results; Affirms FY10 Guidance
Tweet Send to a Friend
Bristol-Myers (NYSE: BMY) reports Q3 EPS of $0.59 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
